Clinical Trial Update: Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer

View source ↗

Summary

A prospective observational study evaluating insulin sensitivity during and after GnRH agonist therapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Gonadotropin-releasing hormone agonist therapy

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer | Status: COMPLETED